Dr. Mintzer has been involved in clinical research on Alzheimer’s disease for the last 20 years and is author of over 240 peer-reviewed research articles. Dr. Mintzer has devoted most of his career to the understanding and the development of treatments for neuropsychiatric symptoms of dementia. Currently, Dr. Mintzer serves as Principal Investigator for the Life’s end Benefits of CannaBidiol and TetrahYdrocannabinol (LiBBY) Trial (R01 AG068324).

Appointments and Honors

• Professor, Department of Health Sciences, Medical University of South Carolina
• Visiting professor, Hebrew University in Jerusalem, Israel
• Honorary professor, University of Exeter, United Kingdom
• Former President, International Psychogeriatric Association
• Former Executive Director, Roper St. Francis Healthcare System Clinical Biotechnology Research Institute